株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

バイオマーカー技術の世界市場の予測 ~2022年:クロマトグラフィ・NGS・PCR・質量分析・免疫測定・リキッドバイオプシー (ddPCR・DHPLC)

Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy (ddPCR, DHPLC)), Research Area (Proteomics, Lipidomics), Application - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 635156
出版日 ページ情報 英文 130 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.66円で換算しております。
Back to Top
バイオマーカー技術の世界市場の予測 ~2022年:クロマトグラフィ・NGS・PCR・質量分析・免疫測定・リキッドバイオプシー (ddPCR・DHPLC) Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy (ddPCR, DHPLC)), Research Area (Proteomics, Lipidomics), Application - Global Forecast to 2022
出版日: 2018年05月07日 ページ情報: 英文 130 Pages
担当者のコメント
MarketsandMarketsのスタンダードなレポートと違い、プレゼン形式にて編集されているレポートです。?質量分析及び クロマトグラフィに関しては企業シェアのデータが記載されています。
概要

世界のバイオマーカー技術の市場は予測期間中9.7%のCAGR (年間複合成長率) で推移し、2017年の469億7000万米ドルから、2022年には745億1000万米ドルの規模に成長すると予測されています。医療費の増加とR&D資金の増加、診断用途でのバイオマーカー利用の拡大、バイオマーカー研究の新たなイニチアチブなどの要因が同市場の成長を推進しています。

当レポートでは、世界のバイオマーカー技術の市場を調査し、市場の定義と概要、市場成長への影響因子および市場機会の分析、検査タイプ・用途・技術・製品など各種区分別の動向と市場規模の推移と予測、市場シェアの分析などをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 バイオマーカー技術市場の分析・予測:検査タイプ別

  • イントロダクション
  • 固体生検
  • リキッドバイオプシー

第4章 リキッドバイオプシー用バイオマーカー市場の分析・予測:用途別

  • イントロダクション
  • 臨床診断
  • 研究
  • 創薬・開発

第5章 リキッドバイオプシー市場の分析・予測:技術別

  • DDPCR
  • NGS
  • 質量分析
  • DHPLC
  • その他

第6章 バイオマーカー技術市場の分析・予測:製品別

  • 消耗品
  • 機器
  • サービス
  • ソフトウェア/インフォマティクス

第7章 バイオマーカー製品市場の分析・予測:用途別

  • 消耗品
    • 診断
      • 臨床利用
      • 研究
    • 創薬・開発
  • 機器
    • 診断
      • 臨床利用
      • 研究
    • 創薬・開発
  • サービス
    • 診断
      • 臨床利用
      • 研究
    • 創薬・開発
  • ソフトウェア/インフォマティクス
    • 診断
      • 臨床利用
      • 研究
    • 創薬・開発

第8章 バイオマーカー技術市場の分析・予測:プロファイリング技術別

  • 免疫測定
    • ELISA
    • ウェスタンブロッティング
    • タンパク質マイクロアレイ
  • PCR
  • 質量分析
  • NGS
  • クロマトグラフィ
  • 画像技術
  • 細胞遺伝学
  • その他

第9章 バイオマーカープロファイリング技術市場の分析・予測:用途別

  • 免疫測定
  • PCR
  • 質量分析
  • NGS
  • 画像技術
  • 細胞遺伝学
  • その他
    • 臨床診断
    • 研究
    • 創薬・開発

第10章 バイオマーカー市場の分析・予測:疾患区分・用途別

  • 感染症
  • 自己免疫疾患
  • 神経系疾患
  • 心臓血管疾患
  • その他
    • 診断
      • 臨床利用
      • 研究
    • 創薬・開発

第11章 バイオマーカー技術市場の分析・予測:用途別

  • バイオマーカーの同定・バリデーション・開発・研究
  • バイオマーカーベースのルーチンテスト

第12章 バイオマーカー技術市場の分析・予測:用途・製品別

  • バイオマーカーの同定・バリデーション・開発・研究
  • バイオマーカーベースのルーチンテスト
    • 消耗品
    • 機器
    • サービス
    • ソフトウェア

第13章 バイオマーカー技術市場の分析・予測:研究分野別

  • ゲノミクス
  • プロテオミクス
  • メタボロミクス
  • その他

第14章 市場シェア分析

  • 質量分析
  • クロマトグラフィ

第15章 バイオマーカー技術市場の分析・予測:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • その他
図表

LIST OF TABLES

  • TABLE 1: GLOBAL BIOMARKERS TESTS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 2: NORTH AMERICA: BIOMARKERS TESTS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 3: GLOBAL BIOMARKERS MARKET, BY TEST TYPE, 2015-2022 (USD BILLION)
  • TABLE 4: GLOBAL BIOMARKERS LIQUID BIOPSY MARKET, BY APPLICATION, 2017-2022 (USD BILLION)
  • TABLE 5: GLOBAL BIOMARKERS LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2017-2022 (USD BILLION)
  • TABLE 6: GLOBAL BIOMARKERS MARKET, BY PRODUCT, 2015-2022 (USD BILLION)
  • TABLE 7: GLOBAL BIOMARKERS CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD BILLION)
  • TABLE 8: GLOBAL BIOMARKERS PRODUCTS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 9: NORTH AMERICA: BIOMARKERS PRODUCTS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 10: GLOBAL CONSUMABLES MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 11: GLOBAL REAGENTS & KITS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 12: NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 13: GLOBAL CHROMATOGRAPHY COLUMNS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 14: GLOBAL INSTRUMENTS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 15: NORTH AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 16: GLOBAL SERVICES MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 17: NORTH AMERICA: SERVICES MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 18: GLOBAL SOFTWARE/INFORMATICS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 19: NORTH AMERICA: SOFTWARE/INFORMATICS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 20: GLOBAL CONSUMABLES MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 21: GLOBAL CONSUMABLES MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 22: GLOBAL CONSUMABLES MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 23: GLOBAL CONSUMABLES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 24: GLOBAL INSTRUMENTS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 25: GLOBAL INSTRUMENTS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 26: GLOBAL INSTRUMENTS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 27: GLOBAL INSTRUMENTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 28: GLOBAL SERVICES MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 29: GLOBAL SERVICES MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 30: GLOBAL SERVICES MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 31: GLOBAL SERVICES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 32: GLOBAL SOFTWARE/INFORMATICS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 33: GLOBAL SOFTWARE/INFORMATICS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 34: GLOBAL SOFTWARE/INFORMATICS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 35: GLOBAL SOFTWARE/INFORMATICS MARKET FOR DRUG DEVELOPMENT & DISCOVERY, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 36: GLOBAL BIOMARKERS MARKET, BY PROFILING TECHNOLOGY, 2015-2022 (USD BILLION)
  • TABLE 37: GLOBAL BIOMARKERS MARKET FOR IMMUNOASSAYS, BY TYPE, 2015-2022 (USD BILLION)
  • TABLE 38: GLOBAL BIOMARKERS MARKET FOR PROFILING TECHNOLOGIES, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 39: NORTH AMERICA: BIOMARKERS MARKET FOR PROFILING TECHNOLOGIES, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 40: GLOBAL IMMUNOASSAYS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 41: GLOBAL ELISA MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 42: NORTH AMERICA: IMMUNOASSAYS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 43: GLOBAL ELISA MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 44: GLOBAL WESTERN BLOT MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 45: GLOBAL PROTEIN MICROARRAY MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 46: NORTH AMERICA: WESTERN BLOT MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 47: GLOBAL PROTEIN MICROARRAY MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 48: KEY EVOLUTIONARY MILESTONES IN THE FIELD OF QPCR/DPCR
  • TABLE 49: GLOBAL PCR MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 50: NORTH AMERICA: PCR MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 51: GLOBAL MASS SPECTROMETRY MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 52: NORTH AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 53: LIST OF SEQUENCING PLATFORMS LAUNCHED BY MARKET PLAYERS DURING 2015-2017
  • TABLE 54: GLOBAL NGS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 55: NORTH AMERICA: NGS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 56: GLOBAL CHROMATOGRAPHY MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 57: NORTH AMERICA: CHROMATOGRAPHY MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 58: GLOBAL IMAGING TECHNOLOGY MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 59: GLOBAL CYTOGENETICS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 60: NORTH AMERICA: IMAGING TECHNOLOGY MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 61: NORTH AMERICA: CYTOGENETICS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 62: GLOBAL BIOMARKERS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 63: NORTH AMERICA: BIOMARKERS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 64: GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR IMMUNOASSAY, BY APPLICATION, 2017-2022 (USD BILLION)
  • TABLE 65: GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR PCR, BY APPLICATION, 2017-2022 (USD BILLION)
  • TABLE 66: GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR MASS SPECTROMETRY, BY APPLICATION, 2017-2022 (USD BILLION)
  • TABLE 67: GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR NGS, BY APPLICATION, 2017-2022 (USD BILLION)
  • TABLE 68: GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR IMAGING TECHNOLOGY, BY APPLICATION, 2017-2022 (USD BILLION)
  • TABLE 69: GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR CYTOGENETICS, BY APPLICATION, 2017-2022 (USD BILLION)
  • TABLE 70: GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR OTHER TECHNOLOGIES, BY APPLICATION, 2017-2022 (USD BILLION)
  • TABLE 71: GLOBAL BIOMARKERS MARKET, BY DISEASE INDICATION, 2015-2022 (USD BILLION)
  • TABLE 72: GLOBAL CANCER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 73: NORTH AMERICA: CANCER BIOMARKERS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 74: GLOBAL CANCER BIOMARKERS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 75: GLOBAL CANCER BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 76: GLOBAL CANCER BIOMARKERS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 77: GLOBAL CANCER BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 78: GLOBAL INFECTIOUS DISEASE BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 79: NORTH AMERICA: INFECTIOUS DISEASE BIOMARKERS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 80: GLOBAL INFECTIOUS DISEASE BIOMARKERS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 81: GLOBAL INFECTIOUS DISEASE BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 82: GLOBAL INFECTIOUS DISEASE BIOMARKERS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 83: GLOBAL INFECTIOUS DISEASE BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 84: GLOBAL AUTOIMMUNE DISORDER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 85: NORTH AMERICA: AUTOIMMUNE DISORDER BIOMARKERS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 86: GLOBAL AUTOIMMUNE DISORDER BIOMARKERS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 87: GLOBAL AUTOIMMUNE DISORDER BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 88: GLOBAL AUTOIMMUNE DISORDER BIOMARKERS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 89: GLOBAL AUTOIMMUNE DISORDER BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 90: GLOBAL NEUROLOGICAL DISORDER BIOMARKERS MARKET, BY TYPE, 2015-2022 (USD BILLION)
  • TABLE 91: GLOBAL NEUROLOGICAL DISORDER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 92: NORTH AMERICA: NEUROLOGICAL DISORDER BIOMARKERS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 93: GLOBAL DEGENERATIVE DISORDER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 94: GLOBAL OTHER NEUROLOGICAL DISORDER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 95: GLOBAL DEGENERATIVE DISORDER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 96: GLOBAL OTHER NEUROLOGICAL DISORDER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 97: GLOBAL NEUROLOGICAL DISORDER BIOMARKERS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 98: GLOBAL NEUROLOGICAL DISORDER BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 99: GLOBAL NEUROLOGICAL DISORDER BIOMARKERS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 100: GLOBAL NEUROLOGICAL DISORDER BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 101: GLOBAL CARDIOVASCULAR DISEASE BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 102: NORTH AMERICA: CARDIOVASCULAR DISEASE BIOMARKERS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 103: GLOBAL CARDIOVASCULAR DISEASE BIOMARKERS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 104: GLOBAL CARDIOVASCULAR DISEASE BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 105: GLOBAL CARDIOVASCULAR DISEASE BIOMARKERS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 106: GLOBAL CARDIOVASCULAR DISEASE BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 107: GLOBAL OTHER DISEASE BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 108: NORTH AMERICA: OTHER DISEASE BIOMARKERS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 109: GLOBAL OTHER DISEASE BIOMARKERS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 110: GLOBAL OTHER DISEASE BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 111: GLOBAL OTHER DISEASE BIOMARKERS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 112: GLOBAL OTHER DISEASE BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 113: GLOBAL BIOMARKERS MARKET, BY SYSTEM, 2015-2022 (USD BILLION)
  • TABLE 114: GLOBAL BIOMARKER IDENTIFICATION, VALIDATION & DEVELOPMENT RESEARCH MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 115: GLOBAL ROUTINE BIOMARKER-BASED TESTS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 116: BIOMARKER IDENTIFICATION, VALIDATION AND DEVELOPMENT RESEARCH, BY PRODUCT, 2017-2022 (USD BILLION)
  • TABLE 117: ROUTINE BIOMARKER BASED TEST / ASSAYS FOR CLINICAL USE, BY PRODUCT, 2017-2022 (USD BILLION)
  • TABLE 118: GLOBAL BIOMARKERS MARKET, BY RESEARCH TYPE, 2015-2022 (USD BILLION)
  • TABLE 119: GLOBAL BIOMARKER IDENTIFICATION, VALIDATION AND DEVELOPMENT RESEARCH MARKET, BY RESEARCH TYPE, 2015-2022 (USD BILLION)
  • TABLE 120: GLOBAL GENOMICS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 121: GLOBAL PROTEOMICS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 122: GLOBAL METABOLOMICS MARKET, BY TYPE, 2015-2022 (USD BILLION)
  • TABLE 123: GLOBAL METABOLOMICS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 124: GLOBAL LIPIDOMICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 125: GLOBAL METABOLIC FLUX MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 126: GLOBAL OTHER METABOLOMICS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 127: GLOBAL MICROBIOME MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 128: GLOBAL OTHER RESEARCH TYPES MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 129: STRENGTH OF PRODUCT PORTFOLIO (KEY PLAYERS)
  • TABLE 130: BUSINESS STRATEGY EXCELLENCE (KEY PLAYERS)
  • TABLE 131: STRENGTH OF PRODUCT PORTFOLIO (KEY PLAYERS)
  • TABLE 132: BUSINESS STRATEGY EXCELLENCE (KEY PLAYERS)
  • TABLE 133: GLOBAL BIOMARKER MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 134: NORTH AMERICA: BIOMARKER MARKET, BY COUNTRY, 2015-2022 (USD BILLION)

LIST OF FIGURES

  • FIGURE 1: PARADIGM SHIFT: RX TO CDX
  • FIGURE 2: BIOMARKER DISCOVERY: TRADITIONAL VS. CONVENTIONAL
  • FIGURE 3: NUMBER OF PUBLICATIONS USING MALDI MSI
  • FIGURE 4: PROTEOMICS APPROACH: AUTOIMMUNE DISEASE BIOMARKER DISCOVERY
  • FIGURE 5: METABOLOMICS PLATFORM SHOWING FLOW OF INFORMATION OF METABOLITES
  • FIGURE 6: GLOBAL BIOMARKERS MARKET FOR MASS SPECTROMETRY: MARKET SHARE ANALYSIS, BY KEY PLAYER
  • FIGURE 7: GLOBAL BIOMARKERS MARKET FOR CHROMATOGRAPHY: MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017
目次
Product Code: MD 6249

"The biomarker technologies market is projected to grow at a CAGR of 9.7%."

The biomarker technologies market is expected to reach USD 74.51 billion in 2022 from USD 46.97 billion in 2017, at a CAGR of 9.7% during the forecast period

The growth of this market is mainly driven by increasing healthcare expenditure and the increase in R&D funding. Other important factors aiding the growth of this market include the increasing utility of biomarkers for diagnostic purposes and new initiatives for biomarker research. Moreover, the emergence of companion diagnostics (CDx) has further intensified biomarker R&D activities. However, significant capital investments are required for the discovery, development, and validation of biomarkers. This is a major factor restraining the growth of the biomarker technologies market.

Immunoassays held the largest share of the biomarker technologies market, by profiling technology, in 2017.

Based on profiling technology, the biomarker technologies market is classified into immunoassay, PCR, imaging technology, mass spectrometry, NGS, chromatography, cytogenetics, and other technologies. The immunoassay segment accounted for the largest share of the market. This segment is further divided into the ELISA, western blot, and protein microarray segment. The protein microarray segment is expected to grow at the fastest pace during the forecast period, mainly due to its increasing use in drug discovery. Moreover, it reduces the time taken, costs, and reagent consumption. This market is driven by advances in the field of proteomics and improvements in the field of recombinant proteins.

Genomics held the largest share of the biomarker technologies market, by research area, in 2017

Based on research area, this market is classified into genomics, proteomics, metabolomics, and other research areas. The focus on biomarker research in the field of genomics is growing with the advent of innovative technologies such as NGS, microarrays, and dPCR; this is supporting market growth.

Cancer was estimated to dominate the biomarker technologies market, by disease indication, in 2017

Based on disease indication, the biomarker technologies market is classified into cancer, infectious diseases, autoimmune disorders, neurological disorders, cardiovascular disorders, and other disease indications. Cancer accounted for the largest share of the biomarker technologies market, as biomarkers have major applications in cancer research, diagnostics, and treatment.

Break-up profile of primaries::

  • By Company Type: Tier 1-42%, Tier 2-37%, and Tier 3-21%.
  • By Designation: C-level-34%, D-level-42%, and Others-24%
  • By Region: North America-32%, Europe-30%, Asia-24%, and RoW-14%

The key players in this market are: Agilent Technologies (US), Thermo Fisher Scientific (US), Roche (Switzerland), Waters Corporation (US), Danaher Corporation (US), Shimadzu Corporation (Japan), and Bio-Rad Laboratories (US).

Research Coverage:

In this report, the biomarker technologies market is segmented by test type, product, application, profiling technology, disease indication, system, and research type. Specific segments have also been studied based on application-clinical diagnostics, drug discovery & development, and applied research. The biomarker systems market has also been classified based on products used.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the portfolios of the top players in the biomarker technologies market. The report analyzes the market by test type, product, application, profiling technology, disease indication, system, research type, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the biomarker technologies market.
  • Market Development: Comprehensive information about lucrative emerging markets-the report analyzes the markets for biomarker technologies market products across regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the biomarker technologies market.
  • Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of key players in the biomarker technologies market for mass spectrometry and chromatography.

TABLE OF CONTENTS

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. BIOMARKER TECHNOLOGIES MARKET, BY TEST TYPE

  • 3.1. INTRODUCTION
  • 3.2. SOLID BIOPSY
  • 3.3. LIQUID BIOPSY

4. BIOMARKERS LIQUID BIOPSY MARKET, BY APPLICATION

  • 4.1. INTRODUCTION
  • 4.2. CLINICAL DIAGNOSTICS
  • 4.3. RESEARCH
  • 4.4. DRUG DISCOVERY AND DEVELOPMENT

5. LIQUID BIOPSY MARKET, BY TECHNOLOGY

  • 5.1. DDPCR
  • 5.2. NGS
  • 5.3. MASS SPECTROMETRY
  • 5.4. DHPLC
  • 5.5. OTHER

6. BIOMARKER TECHNOLOGIES MARKET, BY PRODUCT

  • 6.1. CONSUMABLES
  • 6.2. INSTRUMENTS
  • 6.3. SERVICES
  • 6.4. SOFTWARE/INFORMATICS

7. BIOMARKER PRODUCT MARKET, BY APPLICATION

  • 7.1. CONSUMABLES
    • 7.1.1. DIAGNOSTICS
      • 7.1.1.1. CLINICAL USE
      • 7.1.1.2. RESEARCH
    • 7.1.2. DRUG DISCOVERY & DEVELOPMENT
  • 7.2. INSTRUMENTS
    • 7.2.1. DIAGNOSTICS
      • 7.2.1.1. CLINICAL USE
      • 7.2.1.2. RESEARCH
    • 7.2.2. DRUG DISCOVERY & DEVELOPMENT
  • 7.3. SERVICES
    • 7.3.1. DIAGNOSTICS
      • 7.3.1.1. CLINICAL USE
      • 7.3.1.2. RESEARCH
    • 7.3.2. DRUG DISCOVERY & DEVELOPMENT
  • 7.4. SOFTWARE/INFORMATICS
    • 7.4.1. DIAGNOSTICS
      • 7.4.1.1. CLINICAL USE
      • 7.4.1.2. RESEARCH
    • 7.4.2. DRUG DISCOVERY & DEVELOPMENT

8. BIOMARKER TECHNOLOGIES MARKET, BY PROFILING TECHNOLOGY

  • 8.1. IMMUNOASSAY
    • 8.1.1. ELISA
    • 8.1.2. WESTERN BLOT
    • 8.1.3. PROTEIN MICROARRAY
  • 8.2. PCR
  • 8.3. MASS SPECTROMETRY
  • 8.4. NGS
  • 8.5. CHROMATOGRAPHY
  • 8.6. IMAGING TECHNOLOGIES
  • 8.7. CYTOGENETICS
  • 8.8. OTHERS

9. BIOMARKER PROFILING TECHNOLOGY MARKET, BY APPLICATION

  • 9.1. IMMUNOASSAY
    • 9.1.1. CLINICAL DIAGNOSTICS
    • 9.1.2. RESEARCH
    • 9.1.3. DRUG DISCOVERY AND DEVELOPMENT
  • 9.2. PCR
    • 9.2.1. CLINICAL DIAGNOSTICS
    • 9.2.2. RESEARCH
    • 9.2.3. DRUG DISCOVERY AND DEVELOPMENT
  • 9.3. MASS SPECTROMETRY
    • 9.3.1. CLINICAL DIAGNOSTICS
    • 9.3.2. RESEARCH
    • 9.3.3. DRUG DISCOVERY AND DEVELOPMENT
  • 9.4. NGS
    • 9.4.1. CLINICAL DIAGNOSTICS
    • 9.4.2. RESEARCH
    • 9.4.3. DRUG DISCOVERY AND DEVELOPMENT
  • 9.5. IMAGING TECHNOLOGIES
    • 9.5.1. CLINICAL DIAGNOSTICS
    • 9.5.2. RESEARCH
    • 9.5.3. DRUG DISCOVERY AND DEVELOPMENT
  • 9.6. CYTOGENETICS
    • 9.6.1. CLINICAL DIAGNOSTICS
    • 9.6.2. RESEARCH
    • 9.6.3. DRUG DISCOVERY AND DEVELOPMENT
  • 9.7. OTHERS
    • 9.7.1. CLINICAL DIAGNOSTICS
    • 9.7.2. RESEARCH
    • 9.7.3. DRUG DISCOVERY AND DEVELOPMENT

10. BIOMARKER DISEASE INDICATION MARKET, BY APPLICATION

  • 10.1. CANCER
    • 10.1.1. DIAGNOSTICS
      • 10.1.1.1. CLINICAL USE
      • 10.1.1.2. RESEARCH
    • 10.1.2. DRUG DISCOVERY & DEVELOPMENT
  • 10.2. INFECTIOUS DISEASES
    • 10.2.1. DIAGNOSTICS
      • 10.2.1.1. CLINICAL USE
      • 10.2.1.2. RESEARCH
    • 10.2.2. DRUG DISCOVERY & DEVELOPMENT
  • 10.3. AUTOIMMUNE DISORDERS
    • 10.3.1. DIAGNOSTICS
      • 10.3.1.1. CLINICAL USE
      • 10.3.1.2. RESEARCH
    • 10.3.2. DRUG DISCOVERY & DEVELOPMENT
  • 10.4. NEUROLOGICAL DISORDERS
    • 10.4.1. DIAGNOSTICS
      • 10.4.1.1. CLINICAL USE
      • 10.4.1.2. RESEARCH
    • 10.4.2. DRUG DISCOVERY & DEVELOPMENT
  • 10.5. CARDIOVASCULAR DISORDERS
    • 10.5.1. DIAGNOSTICS
      • 10.5.1.1. CLINICAL USE
      • 10.5.1.2. RESEARCH
    • 10.5.2. DRUG DISCOVERY & DEVELOPMENT
  • 10.6. OTHER
    • 10.6.1. DIAGNOSTICS
      • 10.6.1.1. CLINICAL USE
      • 10.6.1.2. RESEARCH
    • 10.6.2. DRUG DISCOVERY & DEVELOPMENT

11. BIOMARKER TECHNOLOGIES MARKET, BY APPLICATION

  • 11.1. BIOMARKER IDENTIFICATION, VALIDATION & DEVELOPMENT RESEARCH
  • 11.2. ROUTINE BIOMARKER-BASED TESTS

12. BIOMARKER TECHNOLOGY APPLICATIONS MARKET, BY PRODUCT

  • 12.1. BIOMARKER IDENTIFICATION, VALIDATION & DEVELOPMENT RESEARCH
    • 12.1.1. CONSUMABLES
    • 12.1.2. INSTRUMENTS
    • 12.1.3. SERVICES
    • 12.1.3. SOFTWARE
  • 12.2. ROUTINE BIOMARKER-BASED TESTS
    • 12.2.1. CONSUMABLES
    • 12.2.2. INSTRUMENTS
    • 12.2.3. SERVICES
    • 12.2.3. SOFTWARE

13. BIOMARKER TECHNOLOGIES MARKET, BY RESEARCH AREA

  • 13.1. GENOMICS
  • 13.2. PROTEOMICS
  • 13.3. METABOLOMICS
    • 13.3.1. METABOLIC FLUX
    • 13.3.2. LIPIDOMICS
    • 13.3.3. OTHERS
  • 13.4. OTHER RESEARCH TYPES

14. MARKET SHARE ANALYSIS

  • 14.1. BIOMARKER TECHNOLOGIES MARKET FOR MASS SPECTROMETRY: MARKET SHARE ANALYSIS
  • 14.2. BIOMARKER TECHNOLOGIES MARKET FOR CHROMATOGRAPHY: MARKET SHARE ANALYSIS

15. BIOMARKER TECHNOLOGIES MARKET, BY REGION

  • 15.1. NORTH AMERICA
    • 15.1.1. US
    • 15.1.2. CANADA
  • 15.2. EUROPE
  • 15.3. ASIA PACIFIC
  • 15.4. ROW
Back to Top